Special Issue "Human Papillomavirus and Cancers"

A special issue of Cancers (ISSN 2072-6694).

Deadline for manuscript submissions: 31 December 2019

Special Issue Editors

Guest Editor
Dr. Maria Lina Tornesello

Department of Translational Research, Istituto Nazionale Tumori, IRCCS, Fondazione Pascale, Napoli 80131, Italy
Guest Editor
Dr. Franco M. Buonaguro

Molecular Biology and Viral Oncology Unit, Istituto Nazionale Tumori IRCCS Fondazione Pascale, 80131 Naples, Italy
Website | E-Mail
Interests: oncology; molecular biology; virology; biochemistry

Special Issue Information

Dear Colleagues,

The human papillomaviruses (HPV) are the major cause of nearly all cervical cancers and of a significant fraction of several other human malignancies arising from the mucosal squamous epithelia of anus, vagina, vulva, penis, and oropharynx. Despite the great long-term promise of HPV vaccination for the global prevention of cervical cancer, HPV-related cancers will remain a major health problem for decades to come.

The long-term persistent infection, the integration of the viral DNA in the human genome, and the constitutive expression of HPV oncoproteins cause the accumulation of various molecular changes in the infected cells leading to cancer development and progression. Many genetic and epigenetic alterations, as well as complex molecular networks, have been identified by “omics” technologies in HPV-related cancers.

We welcome submissions of research and review articles on the molecular mechanisms that contribute to HPV-induced carcinogenesis to bring together expert opinions and new advances from across the field in a Special Issue of Cancers. We welcome submissions that cover any relevant topic, including the role of oncoviral proteins in cell transformation, the gene mutational profile of viral and host genomes, expression levels of miRNAs, gene methylation, immune response, and new therapeutic opportunities including cancer vaccines for HPV-related cancers.

Dr. Maria Lina Tornesello
Dr. Franco M. Buonaguro
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Published Papers

This special issue is now open for submission.
Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top